Iterum Therapeutics Plc (ITRM) Misses Q2 EPS by 23c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.95), $0.23 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Morgan Stanley downgrades Chinese luxury auto dealers on weak demand
• BTIG Starts Equinix (EQIX) at Buy